Trusted News Discovery Since 2008
{{/content}}
FDA Warns Against Combining Remdesivir And Hydroxychloroquine
Video Credit: Wochit News
Published on June 16, 2020 - Duration: 00:31s
FDA Warns Against Combining Remdesivir And Hydroxychloroquine
The FDA has issued a warning to healthcare providers regarding two medications being tested with COVID-19.
The warning cautions against administering hydroxychloroquine in combination with remdesivir.
According to Reuters, the agency said the co-administration may result in the reduced effectiveness of remdesivir.
Remdesivir is currently the only medication to show benefits against COVID-19 in clinical trials.
You are here
Related videos from verified sources
Trump Criticizes FDA Over Hydroxychloroquine Decision 00:32
Video credit: Wochit Tech - Published on June 16, 2020
FDA Pulls Emergency Authorization For Hydroxychloroquine 00:37
Video credit: Wochit Entertainment - Published on June 15, 2020
Trump Says Hydroxychloroquine Treats COVID-19, Scientists Disagree 00:36
Video credit: Wochit Entertainment - Published on June 15, 2020